Allergan Bid Nears $53 Billion

Valeant Pharmaceuticals boosted its takeover bid for Botox-maker Allergan for the second time this week, offering about $52.7 billion in cash and stock.



from WSJ.com: US Business http://ift.tt/1nLvq9t

via IFTTT